GENC ET AL.
3
δ = 1.08 (s, 3H), 1.17 (s, 3H), 3.79 (dd, J = 4.3, 11.5 Hz,
1H), 4.74 (dd, J = 4.3, 13.5 Hz, 1H), 4.84 to 4.90 (m,
1H), 7.19 to 7.21 (m, 2H), 7.24 to 7.27 (m, 2H), 9.40 (s,
1H); 13C NMR (100 MHz, CDCl3): δ = 19.3, 22.5, 48.0,
49.3, 76.9, 115.9, 116.6, 132.0, 132.4, 162.5, 164.4, 205.3;
HPLC (OD‐H column, hexane–IPA = 80:20, l = 254 nm,
4.92 (m, 1H), 7.11 to 7.12 (m, 2H), 7.45 to 7.47 (m, 2H),
9.49 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 18.8,
21.4, 47.4, 47.9, 76.0, 121.9, 130.2, 132.0, 134.0, 204.0;
HPLC (OD‐H column, hexane–IPA = 80:20, l = 254 nm,
0.8 mL/min flux, tr
=
21.55 minutes (major);
15.53 minutes (minor).
0.7 mL/min flux, tr
=
30.50 minutes (major);
16.10 minutes (minor).
(S)‐3‐(2‐methoxyphenyl)‐2,2‐dimethyl‐4‐nitrobutanal (5f)
IR (cm−1): 535, 756, 789, 903, 1095, 1217, 1365, 1415, 1560,
1
(S)‐3‐(4‐chlorophenyl)‐2,2‐dimethyl‐4‐nitrobutanal (5c)
1638, 1716, 2845, 2965, 3007, 3415; H NMR (400 MHz,
IR (cm−1): 532, 779, 840, 902, 1017, 1223, 1359, 1495,
CDCl3): δ = 1.01 (s, 3H), 1.06 (s, 3H), 3.78 (s, 3H), 4.11 to
4.14 (br, 1H), 4.62 to 4.66 (dd, J = 4.6, 13.0 Hz, 1H), 4.82
to 4.84 (dd, J = 10.8, 13.0 Hz, 1H), 6.82 to 6.90 (m, 2H),
7.03 to 7.06 (dd, J = 1.7, 7.7 Hz, 1H), 7.20 to 7.25 (m, 1H),
9.48 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 20.0, 21.0,
42.9, 48.6, 55.4, 75.9, 111.4, 120.9, 124.0, 128.8, 128.9,
156.9, 203.8; HPLC (OD‐H column, hexane–IPA = 80:20,
l = 254 nm, 0.8 mL/min flux, tr = 15.10 minutes (major);
10.10 minutes (minor).
1
1559, 1718, 2848, 2967, 3008, 3418; H NMR (400 MHz,
CDCl3): δ = 1.04 (s, 3H), 1.09 (s, 3H), 3.80 (dd, J = 4.0,
11.2 Hz, 1H), 4.71 (dd, J = 4.0, 13.2 Hz, 1H), 4.81 to
4.88 (m, 1H), 7.11–7.15 (m, 2H), 7.30 to 7.32 (m, 2H),
9.48 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 18.7,
21.7, 47.1, 47.8, 76.0, 129.1, 129.9, 134.0, 134.3, 204.1;
HPLC (OD‐H column, hexane–IPA = 80:20, l = 254 nm,
0.8 mL/min flux, tr
=
20.21 minutes (major);
13.60 minutes (minor).
(S)‐3‐(4‐methylphenyl)‐2,2‐dimethyl‐4‐nitrobutanal (5g)
IR (CM−1): 692, 719, 879, 1118, 1382, 1436, 1471, 1548,
1719, 2718, 2818, 2927, 2979; 1H NMR (400 MHZ,
CDCL3): Δ = 1.01 (S, 3H), 1.17 (S, 3H), 2.25 (S, 3H),
3.71 (DD, J = 4.4, 11.6 HZ, 1H), 4.70 (DD, J = 4.4,
13.2 HZ, 1H), 4.79 (DD, J = 11.2, 13.2 HZ, 1H), 7.09 to
7.12 (M, 2H), 7.15 to 7.17 (M, 2H), 9.56 (S, 1H); 13C
NMR (100 MHZ, CDCL3): Δ = 19.1, 21.0, 22.6, 48.0,
49.0, 75.8, 128.7, 131.8, 204.0; HPLC (OD‐H column,
hexane–IPA = 80:20, L = 254 nm, 1.0 ml/min flux,
tr = 15.21 minutes (major); 11.50 minutes (minor).
(S)‐3‐(3‐bromophenyl)‐2,2‐dimethyl‐4‐nitrobutanal (5d)
IR (cm−1): 668, 769, 808, 994, 1073, 1258, 1374, 1480, 1552,
1721, 2723, 2821, 2965; 1H NMR (400 MHz, CDCl3):
δ = 0.89 (s, 3H), 1.09 (s, 3H), 3.63 to 3.69 (dd, J = 4.0,
11.4 Hz, 1H), 4.59 to 4.63 (dd, J = 4.0, 13.4 Hz, 1H), 4.69
to 4.76 (dd, J = 11.5, 13.3 Hz, 1H), 7.10 to 7.20 (m, 2H),
7.28 to 7.29 (m, 1H), 7.33 to 7.36 (m, 1H), 9.39 (s, 1H); 13C
NMR (100 MHz, CDCl3): δ = 19.0, 21.5, 47.8, 48.3, 75.8,
123.1, 128.0, 129.9, 131.0, 132.4, 137.8, 203.5; HPLC (OD‐
H column, hexane–IPA = 80:20, l = 254 nm, 0.8 mL/min
flux, tr = 20.52 minutes (major); 13.81 minutes (minor).
(S)‐2,2‐dimethyl‐4‐nitro‐3‐(2‐nitrophenyl)butanal (5h)
(S)‐3‐(4‐bromophenyl)‐2,2‐dimethyl‐4‐nitrobutanal (5e)
IR (cm−1): 669, 789, 854, 880, 1211, 1310, 1359, 1380,
1441, 1520, 1730, 2721, 2817, 2969; H NMR (400 MHz,
CDCl3): δ = 1.17 (s, 3H), 1.23 (s, 3H), 4.71 (dd, J = 3.6,
11.8 Hz, 1H), 4.81 (dd, J = 3.6, 13.6 Hz, 1H), 4.94 to
5.01 (m, 1H), 7.47 to 7.54 (m, 2H), 7.62 to 7.66 (m, 1H),
1
IR (cm−1): 642, 763, 782, 832, 892, 1074, 1219, 1358, 1485,
1
1563, 1640, 2848, 2932, 3000, 3415; H NMR (400 MHz,
CDCl3): δ = 1.14 (s, 3H), 1.51 (s, 3H), 3.79 (dd, J = 4.3,
11.6 Hz, 1H), 4.71 (dd, J = 4.3, 13.4 Hz, 1H), 4.87 to
SCHEME 1 One‐step procedure for the synthesis of heteroatom‐bridged calixaromatic‐based chiral catalysts 2a and 2b